Clinical Trials Browser

Recruiting × Interventional × Imatinib Mesylate × Clear all

NCT06124157 2026-03-13

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 3 Recruiting

Burkitt Lymphoma

NCT04877522 2026-03-06

Asciminib Roll-over Study

Phase 4 Recruiting

MyeloidOther hematologic neoplasm

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05493215 2026-02-17

Imatinib TDM in GIST

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06090669 2026-02-17

Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency

Phase 1 Recruiting

Classical hematology

Congenital Bone Marrow Failure Syndromes

NCT06655246 2026-02-05

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Phase 1 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT06889168 2026-01-21

LAMP-2

Phase 1 Recruiting

Lymphangioleiomyomatosis

NCT05152472 2026-01-08

ATEZOGIST

Phase 2 Recruiting

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors

NCT04626024 2025-12-19

TOKIN

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04598009 2025-09-03

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Phase 2 Recruiting

Melanoma

NCT04307576 2025-08-28

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Phase 3 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05385549 2025-08-08

5 Years of Adjuvant Imatinib in Patients With Gastrointestinal Stromal Tumor With a High Risk

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04838041 2025-07-30

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT05722795 2025-07-09

I-CONIC

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06962254 2025-05-08

Imatinib and Trametinib for KRAS-mutated Solid Tumor

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor Cancer

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

Phase 4 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06119789 2025-03-26

MATRIX-Rare

Phase 2 Recruiting

Rare Malignant Neoplasm

NCT04423185 2025-02-11

PLATFORM Study of Precision Medicine for Rare Tumors

Phase 2 Recruiting

Rare Tumor

NCT05009927 2023-09-01

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT04933669 2021-10-12

ZJGIST-01

Phase 2 Recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors